The Solution Structure of the N-terminal Domain of Human Vitronectin
The three-dimensional structure of an N-terminal fragment comprising the first 51 amino acids from human plasma vitronectin, the somatomedin B (SMB) domain, has been determined by two-dimensional NMR approaches. An average structure was calculated, representing the overall fold from a set of 20 mini...
Saved in:
Published in | The Journal of biological chemistry Vol. 279; no. 28; pp. 29359 - 29366 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
American Society for Biochemistry and Molecular Biology
01.07.2004
|
Online Access | Get full text |
Cover
Loading…
Summary: | The three-dimensional structure of an N-terminal fragment comprising the first 51 amino acids from human plasma vitronectin,
the somatomedin B (SMB) domain, has been determined by two-dimensional NMR approaches. An average structure was calculated,
representing the overall fold from a set of 20 minimized structures. The core residues (18â41) overlay with a root mean square
deviation of 2.29 ± 0.62 Ã
. The N- and C-terminal segments exhibit higher root mean square deviations, reflecting more flexibility
in solution and/or fewer long-range NOEs for these regions. Residues 26â30 form a unique single-turn α-helix, the locus where
plasminogen activator inhibitor type-1 (PAI-1) is bound. This structure of this helix is highly homologous with that of a
recombinant SMB domain solved in a co-crystal with PAI-1 (Zhou, A., Huntington, J. A., Pannu, N. S., Carrell, R. W., and Read,
R. J. (2003) Nat. Struct. Biol. 10, 541â544), although the remainder of the structure differs. Significantly, the pattern of disulfide cross-links observed
in this material isolated from human plasma is altogether different from the disulfides proposed for recombinant forms. The
NMR structure reveals the relative orientation of binding sites for cell surface receptors, including an integrin-binding
site at residues 45â47, which was disordered and did not diffract in the co-crystal, and a site for the urokinase receptor,
which overlaps with the PAI-1-binding site. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M401279200 |